Trial intelligence / Profile preview

Prednisone for COVID-19 Viral Pneumonia

NCT04344288Phase 2Terminated

Sponsor
Hospices Civils de Lyon
Start
Apr 2020
Primary completion
Aug 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of prednisone in COVID-19 pneumonia, sponsored by Hospices Civils de Lyon. Started Apr 2020; status: terminated.

02

Drugs

prednisone
03

Conditions

COVID-19 pneumonia

Beyond the preview

Go deeper on NCT04344288.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04344288.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call